Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans)
Launched by RAMSAY GÉNÉRALE DE SANTÉ · Feb 27, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans)" aims to understand the quality of life for transgender individuals. It focuses on exploring their experiences, challenges, and support systems throughout their life and transition journeys. Transgender people often face misunderstandings and stigma, leading to lower quality of life compared to others. This study seeks to gather valuable information using questionnaires that will help researchers better understand these issues and improve support for transgender individuals.
To participate in this study, individuals must identify as transgender and be at least 18 years old. They should be French-speaking and able to use digital tools, as the study will be conducted online. Participants can expect to complete surveys about their quality of life and perceived social support. The information gathered will help shed light on the diverse experiences of transgender people, ultimately aiming to enhance their well-being and ensure their needs are better understood and addressed in society.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Transgender people (having a gender identity or expression that differs from the sex assigned to them at birth);
- * People with any of the following characteristics regarding their trans identity:
- • Consultant in one of the transgender reference centers and services for questions/information on the transition;
- • Integrated or having completed a course of care with or without gender reassignment surgery;
- • Not integrated into a health or care pathway.
- • French-speaking people;
- • Adults;
- • People able to use the tools digital;
- • People with Internet or 4G access (total or limited)
- Exclusion Criteria:
- • People who do not identify as transgender;
- • Non-French speaking people;
- • Minors
- • People who do not know how to handle the tools digital data collection;
- • People without Internet access.
- • Non-French speaking people, unable to speak understand the research questions
- • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administrative
About Ramsay Générale De Santé
Ramsay Générale de Santé is a leading private healthcare provider in France, dedicated to delivering high-quality medical services and advancing healthcare through innovative clinical research. With a robust portfolio of hospitals and clinics, the organization focuses on improving patient outcomes by conducting rigorous clinical trials across various therapeutic areas. Committed to enhancing healthcare solutions, Ramsay Générale de Santé collaborates with healthcare professionals, researchers, and pharmaceutical companies to facilitate groundbreaking studies that contribute to medical knowledge and patient care advancements. Their emphasis on patient safety, ethical standards, and scientific integrity underscores their role as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials